COLORADO SPRINGS, Colo.,
July 8, 2013 /PRNewswire/ -- The
X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company
specializing primarily in cannabinoid formulation-based health and
wellness solutions, is proud to announce that "American Drug War
II: Cannabis Destiny" rated as the highest of all 2013
documentaries with a score of 9.7 out of 10.
The film focuses on the failed U.S. drug war and its affect on a
new generation of children. As IMDB states, "Director
Kevin Booth navigates through the
cutting edge of Cannabis research while becoming a foster parent to
a child court ordered to take powerful mind altering drugs."
http://www.imdb.com/search/title?sort=user_rating&title_type=documentary&year=2013,2013
CFO and SR VP of Business Development of X-Change Corp,
Robert Kane, stated, "It has been
one of the greatest professional experiences of my life to work
with Kevin Booth and his team.
It is a privilege to be part of the project from the inception of
the business plan, through production and release. To have it
#1 on this year's IMDB highest rated documentary list is telling of
the quality of production and the power of the film's
message. This is important because the story speaks to our
country's failed drug policy within a context of inhumane effects
on children in need of treatment. We are thankful that
the documentary includes the poignant story of little Cash
Hyde. The interest in this film is a game changing
moment for both the film and entertainment industry as well as the
Cannabis industry as the film's success establishes that the market
is primed for further investment from media and entertainment
giants to support, fund, and invest in related projects."
The film is available on DirecTV Video on Demand. It is
also available on iTunes:
https://itunes.apple.com/us/movie/american-drug-war-2-cannabis/id635644281?ls=1.
In addition, it is available as a Video on Demand from
Amazon:
http://www.amazon.com/American-Drug-War-Cannabis-Destiny/dp/B00CO0LPWG/ref=sr_1_20?s=instant-video&ie=UTF8&qid=1370536759&sr=1-20.
About The X-Change Corporation
The X-Change Corporation is currently developing new natural
cannabinoid containing products based on innovative formulations to
utilize the unique and potent benefits of the hemp plant. Medicinal
properties of hemp have been known and applied for thousands of
years. With the aid of scientific research The X-Change
Corporation is translating such knowledge into development of
effective cosmeceutical, nutraceutical, and food brands throughout
the world. The Company's cosmetics and nutritional lines will
address personal needs and will evolve with the introduction of new
formulations and products, advancing the Company within the
expanding multibillion-dollar global market.
Forward Looking Statements
This Press Release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934. A statement containing
works such as "anticipate," "seek," intend," "believe," "plan,"
"estimate," "expect," "project," "plan," or similar phrases may be
deemed "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Some or all of
the events or results anticipated by these forward-looking
statements may not occur. Factors that could cause or contribute to
such differences include the future U.S. and global economies, the
impact of competition, and the Company's reliance on existing
regulations regarding the use and development of cannabis-based
drugs. X-Change Corp. does not undertake any duty nor does it
intend to update the results of these forward-looking
statements.
X-Change Corp.
President
Dr. Dorothy Bray
info@xchangecorp.com
www.xchangecorp.com
1.866.326.5595
Investment Inquiries
Robert Kane
CFO, Sr Vp of Business Development
rkane@xchangecorp.com
561.420.4824
SOURCE X-Change Corporation